Literature DB >> 10993660

Phenotypic effects of overexpression of the MMAC1 gene in prostate epithelial cells.

R M Sharrard1, N J Maitland.   

Abstract

The prostate cancer cell lines PC3 and LNCaP have been shown to lack expression of the tumour suppressor gene MMAC1/PTEN, in contrast to the immortalized non-tumorigenic epithelial lines PNT1a and PNT2. We have measured the effects of reintroduction of wild type (wt) and mutant MMAC1 genes on to these genetic backgrounds, using gene constructs expressing either wt MMAC1 or various mutants deficient in the dual specificity phosphatase domain of the protein. Over-expression of wild type PTEN protein induced cell shrinkage and rounding, but did not result in increased levels of classical apoptosis. Permanently transfected lines containing the MMAC1 gene could only be obtained from the PNT cells, as PTEN expression resulted in rapid loss of both tumour lines. In contrast, mutation of the phosphatase domain resulted in partial attenuation of the phenotypic effects of MMAC1 after transient transfection, and also allowed the derivation of permanent tumour cell lines containing the mutated MMAC1 gene. The results suggest that re-expression of wt PTEN is incompatible with survival of human prostate cancer cells in vitro, and that the full biological activity of this common tumour suppressor requires functions additional to the established protein and lipid phosphatase activities in epithelial systems. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993660      PMCID: PMC2363557          DOI: 10.1054/bjoc.2000.1400

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

1.  The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.

Authors:  D Maier; G Jones; X Li; A H Schönthal; O Gratzl; E G Van Meir; A Merlo
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

2.  Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma.

Authors:  U S Bergerheim; K Kunimi; V P Collins; P Ekman
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

3.  Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein.

Authors:  S Rees; J Coote; J Stables; S Goodson; S Harris; M G Lee
Journal:  Biotechniques       Date:  1996-01       Impact factor: 1.993

4.  Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.

Authors:  T M Trybus; A C Burgess; K J Wojno; T W Glover; J A Macoska
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

5.  Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene.

Authors:  O Cussenot; P Berthon; R Berger; I Mowszowicz; A Faille; F Hojman; P Teillac; A Le Duc; F Calvo
Journal:  J Urol       Date:  1991-09       Impact factor: 7.450

6.  The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.

Authors:  M M Georgescu; K H Kirsch; T Akagi; T Shishido; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

8.  Loss of the chromosomal region 10q23-25 in prostate cancer.

Authors:  I C Gray; S M Phillips; S J Lee; J P Neoptolemos; J Weissenbach; N K Spurr
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

9.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

Authors:  I Vermes; C Haanen; H Steffens-Nakken; C Reutelingsperger
Journal:  J Immunol Methods       Date:  1995-07-17       Impact factor: 2.303

10.  Allelic loss on chromosome 10 in prostate adenocarcinoma.

Authors:  M Ittmann
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

View more
  4 in total

1.  Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate.

Authors:  Ryan P McCarthy; Shaobo Zhang; David G Bostwick; Junqi Qian; John N Eble; Mingsheng Wang; Haiqun Lin; Liang Cheng
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

2.  Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process.

Authors:  C A Hart; M Brown; S Bagley; M Sharrard; N W Clarke
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

3.  Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.

Authors:  Gertrud E Feiersinger; Kristina Trattnig; Peter D Leitner; Fabian Guggenberger; Alexander Oberhuber; Sarah Peer; Martin Hermann; Ira Skvortsova; Jana Vrbkova; Jan Bouchal; Zoran Culig; Frédéric R Santer
Journal:  Mol Oncol       Date:  2018-03-15       Impact factor: 6.603

4.  Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis.

Authors:  M Scaltriti; S Bettuzzi; R M Sharrard; A Caporali; A E Caccamo; N J Maitland
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.